Seminars in Hematology
Volume 47, Issue 2 , Pages 156-169, April 2010

Rituximab in Chronic Lymphocytic Leukemia

  • Samantha M. Jaglowski

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH
    • ,
  • John C. Byrd

      Affiliations

    • Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH
    • Corresponding Author InformationAddress correspondence to John C. Byrd, MD, 455B, OSUCCC, 410 W 12th Ave, Columbus, OH 43210

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by grants from Leukemia and Lymphoma Society and The D. Warren Brown Foundation.

PII: S0037-1963(10)00006-5

doi:10.1053/j.seminhematol.2010.01.005

Seminars in Hematology
Volume 47, Issue 2 , Pages 156-169, April 2010

Article Tools